Katja Weckmann
University of Bonn(DE)Max Planck Institute of Psychiatry(DE)
Publications by Year
Research Areas
Autophagy in Disease and Therapy, Treatment of Major Depression, Tryptophan and brain disorders, Endoplasmic Reticulum Stress and Disease, Diet and metabolism studies
Most-Cited Works
- → SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals(2021)287 cited
- → Analysis of SARS-CoV-2-controlled autophagy reveals spermidine, MK-2206, and niclosamide as putative antiviral therapeutics(2020)127 cited
- → Stress-primed secretory autophagy promotes extracellular BDNF maturation by enhancing MMP9 secretion(2021)124 cited
- → Ketamine’s antidepressant effect is mediated by energy metabolism and antioxidant defense system(2017)82 cited
- → Novel Insights into the Cellular Localization and Regulation of the Autophagosomal Proteins LC3A, LC3B and LC3C(2020)61 cited
- → Time-dependent metabolomic profiling of Ketamine drug action reveals hippocampal pathway alterations and biomarker candidates(2014)53 cited
- → Ketamine’s Effects on the Glutamatergic and GABAergic Systems: A Proteomics and Metabolomics Study in Mice(2018)45 cited
- → Metabolomics profiling reveals differential adaptation of major energy metabolism pathways associated with autophagy upon oxygen and glucose reduction(2018)27 cited
- → Stress-primed secretory autophagy drives extracellular BDNF maturation(2020)4 cited
- → Ketamine’s fast antidepressant drug response: Biosignatures and pathways(2017)1 cited